Previous 10 | Next 10 |
IQVIA™ (NYSE: IQV) announces that since September 2020 it has been collaborating with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, on the Phase 3 COVID-19 vaccine clinical trials. The studies leverage IQVIA...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will participate in a virtual fireside chat at the Barclays Global Healthcare Conference on Tuesday, March 09, 2021 at 3:00 p.m. EST. A l...
Most industrial sectors worldwide are pursuing rapid digitalization and the healthcare sector is no exception. Consequently, we think it wise to bet on healthcare services company IQVIA Holdings (IQV), which is strategically positioned to gain from the increasing use of advanced analytics and...
IQVIA Holdings (IQV) announced that its wholly owned subsidiary, IQVIA, priced an an offering of €1.45B in principal amount of senior notes, consisting of €550M in principal amount of senior notes due 2026 and €900M in principal amount of senior notes due 2029.Proceeds to...
PPD went public in February 2020, raising $1.6 billion in gross proceeds in a U.S. IPO. The firm provides contract research services to biopharmaceutical and research organizations worldwide. While Q3 saw strong growth from its COVID-19 study work, I believe the virus and its vari...
IQVIA Inc., a wholly owned subsidiary of IQVIA Holdings (IQV) intends to raise €1.45B in gross proceeds through an offering of senior notes due 2026 and senior notes due 2029.Issuer also intends to deliver a notice of redemption with respect to its outstanding 3.250% senior notes due 2...
IQVIA OCE sees rapid growth, including expanded global OCE rollout by a top-10 pharma company IQVIA ™ (NYSE:IQV) today announced that 140 life science companies in nearly 90 countries have selected Orchestrated Customer Engagement (OCE) as their customer engagemen...
Image source: The Motley Fool. IQVIA Holdings Inc. (NYSE: IQV) Q4 2020 Earnings Call Feb 10, 2021 , 9:00 a.m. ET Operator Continue reading For further details see: IQVIA Holdings Inc. (IQV) Q4 2020 Earnings Call Transcript
IQVIA Holdings Inc. (IQV) Q4 2020 Results Earnings Conference Call February 10, 2021, 9:00 AM ET Company Participants Andrew Markwick - Senior Vice President, Investor Relations and Treasury Ari Bousbib - Chairman and CEO Ron Bruehlman - Executive Vice President and CFO Eric Sherbet - Executi...
The following slide deck was published by IQVIA Holdings Inc. in conjunction with their 2020 Q4 earnings call. For further details see: IQVIA Holdings Inc. 2020 Q4 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...